HomeLENZ • NASDAQ
add
Lenz Therapeutics Inc
Previous close
$30.48
Day range
$29.13 - $30.71
Year range
$16.54 - $38.93
Market cap
861.37M USD
Avg Volume
373.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 5.00M | — |
Operating expense | 21.86M | 52.29% |
Net income | -14.91M | -45.43% |
Net profit margin | -298.24 | — |
Earnings per share | -0.53 | -32.50% |
EBITDA | -16.84M | -17.47% |
Effective tax rate | -3.47% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 209.52M | 6.84% |
Total assets | 217.33M | 7.25% |
Total liabilities | 10.97M | 12.85% |
Total equity | 206.36M | — |
Shares outstanding | 28.52M | — |
Price to book | 4.21 | — |
Return on assets | -20.14% | — |
Return on capital | -21.04% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -14.91M | -45.43% |
Cash from operations | -11.51M | 27.14% |
Cash from investing | -414.00K | 99.58% |
Cash from financing | 26.49M | 1,339.49% |
Net change in cash | 14.57M | 112.52% |
Free cash flow | -6.26M | 64.96% |
About
Founded
2013
Headquarters
Website
Employees
42
